Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

FOPO nets $64.9mm for ChemoCentryx

Executive Summary

ChemoCentryx Inc. (targeting chemokine receptors involved in conditions including autoimmune diseases, inflammatory disorders, and cancer) has netted $64.9mm through a follow-on public offering of 5.75mm common shares (including the overallotment) at $12.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies

UsernamePublicRestriction

Register